var data={"title":"Epidemiology, transmission, natural history, and pathogenesis of HIV-2 infection","body":"<div id=\"topicContent\" class=\"utdArticleSection utdStyle\"><div id=\"topicTitle\">Epidemiology, transmission, natural history, and pathogenesis of HIV-2 infection</div><dl id=\"topicContributors\"><dt><span> </span>Author:</dt><dd><a href=\"https://www.uptodate.com/contents/epidemiology-transmission-natural-history-and-pathogenesis-of-hiv-2-infection/contributors\" class=\"contributor contributor_credentials\">Geoffrey S Gottlieb, MD, PhD</a></dd><dt><span> </span>Section Editor:</dt><dd><a href=\"https://www.uptodate.com/contents/epidemiology-transmission-natural-history-and-pathogenesis-of-hiv-2-infection/contributors\" class=\"contributor contributor_credentials\">John A Bartlett, MD</a></dd><dt><span> </span>Deputy Editor:</dt><dd><a href=\"https://www.uptodate.com/contents/epidemiology-transmission-natural-history-and-pathogenesis-of-hiv-2-infection/contributors\" class=\"contributor contributor_credentials\">Jennifer Mitty, MD, MPH</a></dd></dl><p class=\"disclosureLink\"><a href=\"https://www.uptodate.com/contents/epidemiology-transmission-natural-history-and-pathogenesis-of-hiv-2-infection/contributor-disclosure\" class=\"contributor contributor_credentials\">Contributor Disclosures</a></p><div id=\"reviewProcess\"><span>All topics are updated as new evidence becomes available and our <a href=\"https://www.uptodate.com/home/editorial-policy\" target=\"_blank\" class=\"policy policy_editorialpolicy\">peer review process</a> is complete.</span></div><div id=\"literatureReviewDate\"><span class=\"emphasis\">Literature review current through:</span>&#160;Feb 2018.&#160;&#124;&#160;<span class=\"emphasis\">This topic last updated:</span>&#160;Sep 20, 2016.</div><div id=\"topicWhatsNewContainer\"></div><div id=\"topicText\"><p class=\"headingAnchor\" id=\"H13491378\"><span class=\"h1\">INTRODUCTION</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Although HIV-1 infection is associated with most of the global AIDS pandemic, HIV-2 is an important cause of disease in certain regions of the world where it is endemic. HIV-2 infection has also been described in pockets of locations globally, so it is an important consideration in patients with an AIDS-like illness [<a href=\"https://www.uptodate.com/contents/epidemiology-transmission-natural-history-and-pathogenesis-of-hiv-2-infection/abstract/1\" class=\"abstract_t\">1</a>]. </p><p>This topic will address the epidemiology, transmission, natural history, and pathogenesis of HIV-2 infection. The clinical manifestations, diagnosis, and treatment of HIV-2 are discussed elsewhere. (See <a href=\"topic.htm?path=clinical-manifestations-and-diagnosis-of-hiv-2-infection\" class=\"medical medical_review\">&quot;Clinical manifestations and diagnosis of HIV-2 infection&quot;</a> and <a href=\"topic.htm?path=treatment-of-hiv-2-infection\" class=\"medical medical_review\">&quot;Treatment of HIV-2 infection&quot;</a>.)</p><p class=\"headingAnchor\" id=\"H1426447\"><span class=\"h1\">EPIDEMIOLOGY</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>As of 2015, the World Health Organization (WHO) estimates that approximately 36.7 million people are living with <span class=\"nowrap\">HIV/AIDS;</span> by crude estimates, approximately one to two million of these people are infected with HIV-2 [<a href=\"https://www.uptodate.com/contents/epidemiology-transmission-natural-history-and-pathogenesis-of-hiv-2-infection/abstract/2-4\" class=\"abstract_t\">2-4</a>], including some who are dually infected with both viruses [<a href=\"https://www.uptodate.com/contents/epidemiology-transmission-natural-history-and-pathogenesis-of-hiv-2-infection/abstract/2-7\" class=\"abstract_t\">2-7</a>].</p><p class=\"headingAnchor\" id=\"H1427234\"><span class=\"h2\">Origin of the epidemic</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Serologic evidence of a second human immunodeficiency virus was first discovered in 1985 in Senegal [<a href=\"https://www.uptodate.com/contents/epidemiology-transmission-natural-history-and-pathogenesis-of-hiv-2-infection/abstract/8\" class=\"abstract_t\">8</a>] with subsequent isolation of HIV-2 documented in 1986 from a Cape Verdean patient [<a href=\"https://www.uptodate.com/contents/epidemiology-transmission-natural-history-and-pathogenesis-of-hiv-2-infection/abstract/9\" class=\"abstract_t\">9</a>]. Similar to HIV-1, HIV-2 was initially a zoonosis, originally transmitted from West African Sooty mangabeys to humans [<a href=\"https://www.uptodate.com/contents/epidemiology-transmission-natural-history-and-pathogenesis-of-hiv-2-infection/abstract/10-12\" class=\"abstract_t\">10-12</a>]. Serologic data suggest that HIV-2 may have been circulating as early as 1966 [<a href=\"https://www.uptodate.com/contents/epidemiology-transmission-natural-history-and-pathogenesis-of-hiv-2-infection/abstract/13\" class=\"abstract_t\">13</a>] while phylogenetic evidence dates its introduction into humans during the first half of the 20<sup>th</sup> century [<a href=\"https://www.uptodate.com/contents/epidemiology-transmission-natural-history-and-pathogenesis-of-hiv-2-infection/abstract/14,15\" class=\"abstract_t\">14,15</a>]. (See <a href=\"topic.htm?path=global-epidemiology-of-hiv-infection#H2\" class=\"medical medical_review\">&quot;Global epidemiology of HIV infection&quot;, section on 'Origin of the HIV epidemic'</a>.)</p><p class=\"headingAnchor\" id=\"H1427152\"><span class=\"h2\">HIV-2 in West Africa</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>HIV-2 is endemic in West Africa, although data over the past decade suggest that epidemiologic trends may be shifting [<a href=\"https://www.uptodate.com/contents/epidemiology-transmission-natural-history-and-pathogenesis-of-hiv-2-infection/abstract/16-18\" class=\"abstract_t\">16-18</a>]. Several African countries (eg, Senegal, Gambia, Cote D&rsquo;Ivoire, Guinea-Bissau) have reported declining prevalence rates of HIV-2 over time [<a href=\"https://www.uptodate.com/contents/epidemiology-transmission-natural-history-and-pathogenesis-of-hiv-2-infection/abstract/16-20\" class=\"abstract_t\">16-20</a>].</p><p>As an example, a cross-sectional survey performed from 1996 to 2006 among 3242 individuals living in Guinea-Bissau demonstrated that the incidence of HIV-2 was declining and was half that of HIV-1 infection, when compared with a similar serosurvey from 1987 to 1996 [<a href=\"https://www.uptodate.com/contents/epidemiology-transmission-natural-history-and-pathogenesis-of-hiv-2-infection/abstract/18,21\" class=\"abstract_t\">18,21</a>].</p><p>Additionally, the prevalence of HIV-2 decreased among persons below 45 years of age, but not among older individuals [<a href=\"https://www.uptodate.com/contents/epidemiology-transmission-natural-history-and-pathogenesis-of-hiv-2-infection/abstract/18\" class=\"abstract_t\">18</a>]. This observation may be due to a cohort effect, where previously infected individuals are aging with HIV-2 infection, which is less pathogenic than HIV-1 [<a href=\"https://www.uptodate.com/contents/epidemiology-transmission-natural-history-and-pathogenesis-of-hiv-2-infection/abstract/18\" class=\"abstract_t\">18</a>]. Other explanations include: a) lower rates of sexual transmission of HIV-2 compared with HIV-1 and b) screening of the blood supply for HIV-2, which was initiated in 1987. (See <a href=\"#H1427133\" class=\"local\">'Transmission'</a> below.)</p><p class=\"headingAnchor\" id=\"H1427159\"><span class=\"h2\">HIV-2 outside West Africa</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Regions and countries outside of West Africa reporting HIV-2 infections include: North America (United States, Canada), South America (Brazil, Venezuela), Europe (France, Spain, Portugal, United Kingdom, Sweden, Germany, Italy, Switzerland, Netherlands, Belgium, Greece), the Middle East (Lebanon, Israel, Egypt), Asia-Oceana (India, Philippines, China, Nepal, Japan, Australia, New Zealand), and Southern Africa (Zimbabwe, Angola, Mozambique, South Africa) [<a href=\"https://www.uptodate.com/contents/epidemiology-transmission-natural-history-and-pathogenesis-of-hiv-2-infection/abstract/22,23\" class=\"abstract_t\">22,23</a>]. </p><p>In the United States, the first case of HIV-2 infection was reported in 1987 [<a href=\"https://www.uptodate.com/contents/epidemiology-transmission-natural-history-and-pathogenesis-of-hiv-2-infection/abstract/24\" class=\"abstract_t\">24</a>]. The total number of cases of HIV-2 in the United States is small, with only 166 cases reported to the CDC between 1987 and 2009 [<a href=\"https://www.uptodate.com/contents/epidemiology-transmission-natural-history-and-pathogenesis-of-hiv-2-infection/abstract/25\" class=\"abstract_t\">25</a>]. However, most experts suspect this is a likely underestimate; there have been 62 cases of HIV-2 diagnosed in New York City alone since implementation of HIV reporting in 2000 and many urban areas (eg, Chicago, Boston, Washington, DC) include immigrants from West Africa where HIV-2 is endemic [<a href=\"https://www.uptodate.com/contents/epidemiology-transmission-natural-history-and-pathogenesis-of-hiv-2-infection/abstract/1,26\" class=\"abstract_t\">1,26</a>]. The prevalence of HIV-2 may also be underestimated since most patients with HIV-2 infection are asymptomatic. </p><p class=\"headingAnchor\" id=\"H1426891\"><span class=\"h2\">Dual infection with HIV-1 and HIV-2</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Dual infection with HIV-1 and HIV-2 can occur in locales where both viruses co-circulate [<a href=\"https://www.uptodate.com/contents/epidemiology-transmission-natural-history-and-pathogenesis-of-hiv-2-infection/abstract/5-7\" class=\"abstract_t\">5-7</a>]. Dual infection has been reported most commonly in West Africa where it is estimated that approximately 5 to 10 percent of HIV-infected individuals are coinfected with HIV-2 [<a href=\"https://www.uptodate.com/contents/epidemiology-transmission-natural-history-and-pathogenesis-of-hiv-2-infection/abstract/4,19,27-30\" class=\"abstract_t\">4,19,27-30</a>]. </p><p>Although one observational study in Senegalese female sex workers suggested that HIV-2 infection may be protective against HIV acquisition [<a href=\"https://www.uptodate.com/contents/epidemiology-transmission-natural-history-and-pathogenesis-of-hiv-2-infection/abstract/31\" class=\"abstract_t\">31</a>], these results were not corroborated by subsequent reports [<a href=\"https://www.uptodate.com/contents/epidemiology-transmission-natural-history-and-pathogenesis-of-hiv-2-infection/abstract/32-34\" class=\"abstract_t\">32-34</a>]. </p><p class=\"headingAnchor\" id=\"H1427133\"><span class=\"h1\">TRANSMISSION</span></p><p class=\"headingAnchor\" id=\"H60762404\"><span class=\"h2\">Routes of transmission</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>HIV-1 and HIV-2 share similar routes of transmission including sexual contact, blood-borne exposure (eg, blood transfusions, shared needles) and perinatal transmission. </p><p>Screening of the blood supply has virtually eliminated transmissions via this route in developed countries [<a href=\"https://www.uptodate.com/contents/epidemiology-transmission-natural-history-and-pathogenesis-of-hiv-2-infection/abstract/35\" class=\"abstract_t\">35</a>]. The risk of HIV-2 infection has also declined in some African countries, such as Guinea-Bissau, Senegal, and Cote d'Ivoire, where HIV screening of the blood supply was initiated early in the HIV epidemic [<a href=\"https://www.uptodate.com/contents/epidemiology-transmission-natural-history-and-pathogenesis-of-hiv-2-infection/abstract/21,36,37\" class=\"abstract_t\">21,36,37</a>].</p><p class=\"headingAnchor\" id=\"H60762411\"><span class=\"h2\">Risk of transmission</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Transmission of HIV-2 appears to be less efficient than HIV-1 [<a href=\"https://www.uptodate.com/contents/epidemiology-transmission-natural-history-and-pathogenesis-of-hiv-2-infection/abstract/38-44\" class=\"abstract_t\">38-44</a>]. This is particularly notable when comparing perinatal transmission rates for these two viruses. For example, in studies of pregnant women in The Gambia or the Ivory Coast, the relative risk of transmission was 6- to 21-fold lower among HIV-2 infected compared with HIV-1 infected women [<a href=\"https://www.uptodate.com/contents/epidemiology-transmission-natural-history-and-pathogenesis-of-hiv-2-infection/abstract/40,44\" class=\"abstract_t\">40,44</a>].</p><p>The lower risk of transmission of HIV-2 may be related to lower levels of viremia that are seen among infected patients compared with those with HIV-1. Compared with HIV-1, lower levels of HIV-2 shedding have also been found in the genital tracts of men and women, which may also help to explain the lower rates of HIV-2 transmission through sexual contact [<a href=\"https://www.uptodate.com/contents/epidemiology-transmission-natural-history-and-pathogenesis-of-hiv-2-infection/abstract/38,42,45\" class=\"abstract_t\">38,42,45</a>]. (See <a href=\"#H13491385\" class=\"local\">'Natural history'</a> below.)</p><p class=\"headingAnchor\" id=\"H13491385\"><span class=\"h1\">NATURAL HISTORY</span></p><p class=\"headingAnchor\" id=\"H151845\"><span class=\"h2\">HIV-2 is less pathogenic than HIV-1</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Multiple studies suggest that HIV-2 is generally less pathogenic than HIV-1. Chronic HIV-1 infection is characterized by rising levels of viremia and progressive immunologic decline in association with opportunistic infections that eventually lead to death in the untreated host. Compared with HIV-1, HIV-2 infection is characterized by [<a href=\"https://www.uptodate.com/contents/epidemiology-transmission-natural-history-and-pathogenesis-of-hiv-2-infection/abstract/38-43,45-53\" class=\"abstract_t\">38-43,45-53</a>]: </p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>A longer asymptomatic stage of infection </p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Slower declines of CD4+ T-cell counts</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Lower levels of plasma viremia in chronically-infected patients </p><p/><p class=\"headingAnchor\" id=\"H60761993\"><span class=\"h3\">Risk of AIDS</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>The slower natural history of HIV-2 infection was well illustrated in an observational study in Senegal; 46 HIV-1 infected and 103 HIV-2 infected commercial sex workers were recruited and followed serially from 1985 to 1993 [<a href=\"https://www.uptodate.com/contents/epidemiology-transmission-natural-history-and-pathogenesis-of-hiv-2-infection/abstract/47\" class=\"abstract_t\">47</a>]. Over the course of the study, the probability of AIDS-free survival was higher among HIV-2 compared with HIV-1 infected women (100 percent versus 67 percent). In addition, a subset of women with incident HIV-1 seroconversion (n = 32) were significantly more likely to have a decline in CD4 cell counts (&lt;400 <span class=\"nowrap\">cells/mm<sup>3</sup>)</span> than those with incident HIV-2 seroconversion (n = 33). </p><p class=\"headingAnchor\" id=\"H2601006\"><span class=\"h3\">Risk of death</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>HIV-2 infected patients with a CD4 cell count &gt;500 <span class=\"nowrap\">cells/mm<sup>3</sup></span> appear to have a lower risk of dying compared with HIV-1 infected patients with a similar immune status [<a href=\"https://www.uptodate.com/contents/epidemiology-transmission-natural-history-and-pathogenesis-of-hiv-2-infection/abstract/54\" class=\"abstract_t\">54</a>]. However, mortality rates among HIV-1 and HIV-2 infected patients with advanced disease appear similar when adjusting for CD4 cell count, age, and sex [<a href=\"https://www.uptodate.com/contents/epidemiology-transmission-natural-history-and-pathogenesis-of-hiv-2-infection/abstract/53\" class=\"abstract_t\">53</a>].</p><p class=\"headingAnchor\" id=\"H60762000\"><span class=\"h3\">Lower levels of viremia</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>When matched for disease stage, studies of HIV-2 infected patients demonstrate that plasma viremia is significantly lower compared with HIV-1 infected patients [<a href=\"https://www.uptodate.com/contents/epidemiology-transmission-natural-history-and-pathogenesis-of-hiv-2-infection/abstract/55\" class=\"abstract_t\">55</a>]. Low levels of viremia are also associated with slower declines of CD4 cell counts and lower rates of viral evolution among individual patients with HIV-2 infection compared with those with HIV-1 [<a href=\"https://www.uptodate.com/contents/epidemiology-transmission-natural-history-and-pathogenesis-of-hiv-2-infection/abstract/56\" class=\"abstract_t\">56</a>]. Lower levels of viremia are also seen among recent HIV-2 seroconverters; in one study, the viral load set point was approximately 28-fold lower after seroconversion among those with HIV-2 than with HIV-1 infection [<a href=\"https://www.uptodate.com/contents/epidemiology-transmission-natural-history-and-pathogenesis-of-hiv-2-infection/abstract/57\" class=\"abstract_t\">57</a>]. HIV-2-specific immune responses may help to control viremia in early stages of infection [<a href=\"https://www.uptodate.com/contents/epidemiology-transmission-natural-history-and-pathogenesis-of-hiv-2-infection/abstract/57-60\" class=\"abstract_t\">57-60</a>]. </p><p>However, for each logarithmic increase in viral load in HIV-2 infected patients, the rate of CD4 T cell decline is similar to that seen in HIV-1 infected patients [<a href=\"https://www.uptodate.com/contents/epidemiology-transmission-natural-history-and-pathogenesis-of-hiv-2-infection/abstract/48\" class=\"abstract_t\">48</a>]. Thus, the level of viremia may influence the development of advanced immunodeficiency [<a href=\"https://www.uptodate.com/contents/epidemiology-transmission-natural-history-and-pathogenesis-of-hiv-2-infection/abstract/61\" class=\"abstract_t\">61</a>]. </p><p class=\"headingAnchor\" id=\"H2600297\"><span class=\"h2\">Natural history among dually infected patients</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>The natural history of HIV-1 infection may be altered by coinfection with HIV-2 [<a href=\"https://www.uptodate.com/contents/epidemiology-transmission-natural-history-and-pathogenesis-of-hiv-2-infection/abstract/57,62-71\" class=\"abstract_t\">57,62-71</a>]. As an example, a cohort study found that the median time to AIDS was longer in 32 patients with dual infection compared with 119 patients with HIV-1 alone (104 versus 68 months) [<a href=\"https://www.uptodate.com/contents/epidemiology-transmission-natural-history-and-pathogenesis-of-hiv-2-infection/abstract/68\" class=\"abstract_t\">68</a>]. Extended follow-up of this cohort found that mortality in dually infected individuals was also lower [<a href=\"https://www.uptodate.com/contents/epidemiology-transmission-natural-history-and-pathogenesis-of-hiv-2-infection/abstract/71\" class=\"abstract_t\">71</a>]. However, a meta-analysis that included data from six studies found no difference in mortality between those with dual infection compared with HIV-1 monoinfection (mortality rate ratio 1.11, 95% CI 0.95-1.30) [<a href=\"https://www.uptodate.com/contents/epidemiology-transmission-natural-history-and-pathogenesis-of-hiv-2-infection/abstract/70\" class=\"abstract_t\">70</a>].</p><p class=\"headingAnchor\" id=\"H60762064\"><span class=\"h1\">PATHOGENESIS</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>The mechanisms underlying the divergent natural history patterns between HIV-1 and HIV-2 infections are unclear. </p><p>In patients with HIV-1 infection, systemic immune activation is an independent marker of disease progression [<a href=\"https://www.uptodate.com/contents/epidemiology-transmission-natural-history-and-pathogenesis-of-hiv-2-infection/abstract/72\" class=\"abstract_t\">72</a>]. Immune activation may result from microbial translocation of bacterial cell wall products (eg, lipopolysaccharide), which occurs secondary to HIV-related invasion and disruption of the gastrointestinal mucosa [<a href=\"https://www.uptodate.com/contents/epidemiology-transmission-natural-history-and-pathogenesis-of-hiv-2-infection/abstract/73,74\" class=\"abstract_t\">73,74</a>]. Cross-sectional studies of HIV-infected patients in the United States have demonstrated that different stages of HIV disease are associated with higher levels of circulating lipopolysaccharide (LPS) and markers of monocyte activation (sCD14) and decreased endotoxin core antibody (EndoCAb) levels [<a href=\"https://www.uptodate.com/contents/epidemiology-transmission-natural-history-and-pathogenesis-of-hiv-2-infection/abstract/72,75\" class=\"abstract_t\">72,75</a>]. However, one longitudinal study in Africa did not support a role for microbial translocation among African patients with HIV-1 infection [<a href=\"https://www.uptodate.com/contents/epidemiology-transmission-natural-history-and-pathogenesis-of-hiv-2-infection/abstract/76\" class=\"abstract_t\">76</a>]. These opposing observations may be related to different modes of transmission or differences in baseline cytokine levels due to chronic intestinal infections, which could alter the immune response to HIV-1 infection.</p><p>There are few studies that have examined the role of microbial translocation or chronic immune activation and disease progression among HIV-1 and HIV-2 infected patients [<a href=\"https://www.uptodate.com/contents/epidemiology-transmission-natural-history-and-pathogenesis-of-hiv-2-infection/abstract/55,73,77-80\" class=\"abstract_t\">55,73,77-80</a>]. These observational studies have demonstrated the following key findings:</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Some studies have suggested that HIV-2 infected patients may have lower levels of immune activation compared with those with HIV-1, thus accounting for slower rates of disease progression [<a href=\"https://www.uptodate.com/contents/epidemiology-transmission-natural-history-and-pathogenesis-of-hiv-2-infection/abstract/77\" class=\"abstract_t\">77</a>], while others have found comparable levels among patients with similar stages of clinical disease [<a href=\"https://www.uptodate.com/contents/epidemiology-transmission-natural-history-and-pathogenesis-of-hiv-2-infection/abstract/73\" class=\"abstract_t\">73</a>].</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>There are also conflicting data as to whether there is a direct relationship between viral load and markers of T cell activation [<a href=\"https://www.uptodate.com/contents/epidemiology-transmission-natural-history-and-pathogenesis-of-hiv-2-infection/abstract/55,73,78-80\" class=\"abstract_t\">55,73,78-80</a>]. </p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>However, several studies do suggest that immune activation (as measured by the cellular expression of HLA-DR and CD38 on CD4+ and CD8+ T cells and T cell receptor excision DNA circle [TREC] levels) is directly associated with CD4+ T cell depletion in HIV-2 infected patients, as previously described in HIV-1 infection [<a href=\"https://www.uptodate.com/contents/epidemiology-transmission-natural-history-and-pathogenesis-of-hiv-2-infection/abstract/55,73,77,79\" class=\"abstract_t\">55,73,77,79</a>]. Another study that examined the role of microbial translocation found a direct correlation between increased LPS levels and loss of CD4 T cells among HIV-1 and HIV-2 infected patients alike [<a href=\"https://www.uptodate.com/contents/epidemiology-transmission-natural-history-and-pathogenesis-of-hiv-2-infection/abstract/78\" class=\"abstract_t\">78</a>].</p><p/><p class=\"headingAnchor\" id=\"H603396\"><span class=\"h1\">SUMMARY AND RECOMMENDATIONS</span></p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Similar to HIV-1, HIV-2 was initially a zoonosis, originally transmitted from West African Sooty mangabeys to humans. (See <a href=\"#H1427234\" class=\"local\">'Origin of the epidemic'</a> above.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>HIV-2 is endemic in West Africa, but has also been reported in more than two dozen countries in multiple continents. Accurate estimates on the number of cases worldwide are lacking. (See <a href=\"#H1427159\" class=\"local\">'HIV-2 outside West Africa'</a> above.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Dual infection with HIV-1 and HIV-2 can occur in locales where both viruses cocirculate. (See <a href=\"#H1426891\" class=\"local\">'Dual infection with HIV-1 and HIV-2'</a> above.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>HIV-1 and HIV-2 share similar routes of transmission including sexual contact, blood-borne exposure (eg, blood transfusions, shared needles) and perinatal transmission. (See <a href=\"#H1427133\" class=\"local\">'Transmission'</a> above.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Transmission of HIV-2 appears to be less efficient than HIV-1. This observation may be related to the lower levels of plasma viremia and genital shedding that is observed among HIV-2 infected patients. (See <a href=\"#H1427133\" class=\"local\">'Transmission'</a> above.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Multiple studies suggest that HIV-2 is generally less pathogenic than HIV-1. Compared with HIV-1, HIV-2 infection is characterized by a longer asymptomatic stage of infection, slower declines of CD4 cell counts and lower levels of plasma viremia. (See <a href=\"#H13491385\" class=\"local\">'Natural history'</a> above.)</p></div><div id=\"topicAgreement\">Use of UpToDate is subject to the <a href=\"https://www.uptodate.com/legal/license\" class=\"licenseLink\" id=\"sla_in_page\">Subscription and License Agreement</a>.</div><div id=\"references\" class=\"headingAnchor\"><h1>REFERENCES</h1><ol id=\"reference\"><li><a href=\"https://www.uptodate.com/contents/epidemiology-transmission-natural-history-and-pathogenesis-of-hiv-2-infection/abstract/1\" class=\"nounderline abstract_t\">Campbell-Yesufu OT, Gandhi RT. Update on human immunodeficiency virus (HIV)-2 infection. Clin Infect Dis 2011; 52:780.</a></li><li class=\"breakAll\">http://www.unaids.org/en/media/unaids/contentassets/documents/epidemiology/2013/gr2013/UNAIDS_Global_Report_2013_en.pdf (Accessed on May 23, 2014).</li><li class=\"breakAll\">http://www.cdc.gov/hiv/resources/factsheets/hiv2.htm (Accessed on March 01, 2011).</li><li><a href=\"https://www.uptodate.com/contents/epidemiology-transmission-natural-history-and-pathogenesis-of-hiv-2-infection/abstract/4\" class=\"nounderline abstract_t\">Ari&euml;n KK, Abraha A, Qui&ntilde;ones-Mateu ME, et al. The replicative fitness of primary human immunodeficiency virus type 1 (HIV-1) group M, HIV-1 group O, and HIV-2 isolates. J Virol 2005; 79:8979.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-transmission-natural-history-and-pathogenesis-of-hiv-2-infection/abstract/5\" class=\"nounderline abstract_t\">Cot MC, Poulain M, Delagneau JF, et al. Dual HIV-1 and HIV-2 infection in West Africa supported by synthetic peptide analysis. AIDS Res Hum Retroviruses 1988; 4:239.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-transmission-natural-history-and-pathogenesis-of-hiv-2-infection/abstract/6\" class=\"nounderline abstract_t\">Evans LA, Moreau J, Odehouri K, et al. Simultaneous isolation of HIV-1 and HIV-2 from an AIDS patient. Lancet 1988; 2:1389.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-transmission-natural-history-and-pathogenesis-of-hiv-2-infection/abstract/7\" class=\"nounderline abstract_t\">Rayfield M, De Cock K, Heyward W, et al. Mixed human immunodeficiency virus (HIV) infection in an individual: demonstration of both HIV type 1 and type 2 proviral sequences by using polymerase chain reaction. J Infect Dis 1988; 158:1170.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-transmission-natural-history-and-pathogenesis-of-hiv-2-infection/abstract/8\" class=\"nounderline abstract_t\">Barin F, M'Boup S, Denis F, et al. Serological evidence for virus related to simian T-lymphotropic retrovirus III in residents of west Africa. Lancet 1985; 2:1387.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-transmission-natural-history-and-pathogenesis-of-hiv-2-infection/abstract/9\" class=\"nounderline abstract_t\">Clavel F, Gu&eacute;tard D, Brun-V&eacute;zinet F, et al. Isolation of a new human retrovirus from West African patients with AIDS. Science 1986; 233:343.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-transmission-natural-history-and-pathogenesis-of-hiv-2-infection/abstract/10\" class=\"nounderline abstract_t\">Gao F, Yue L, Robertson DL, et al. Genetic diversity of human immunodeficiency virus type 2: evidence for distinct sequence subtypes with differences in virus biology. J Virol 1994; 68:7433.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-transmission-natural-history-and-pathogenesis-of-hiv-2-infection/abstract/11\" class=\"nounderline abstract_t\">Gao F, Bailes E, Robertson DL, et al. Origin of HIV-1 in the chimpanzee Pan troglodytes troglodytes. Nature 1999; 397:436.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-transmission-natural-history-and-pathogenesis-of-hiv-2-infection/abstract/12\" class=\"nounderline abstract_t\">Gao F, Yue L, White AT, et al. Human infection by genetically diverse SIVSM-related HIV-2 in west Africa. Nature 1992; 358:495.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-transmission-natural-history-and-pathogenesis-of-hiv-2-infection/abstract/13\" class=\"nounderline abstract_t\">Kawamura M, Yamazaki S, Ishikawa K, et al. HIV-2 in west Africa in 1966. Lancet 1989; 1:385.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-transmission-natural-history-and-pathogenesis-of-hiv-2-infection/abstract/14\" class=\"nounderline abstract_t\">Lemey P, Pybus OG, Wang B, et al. Tracing the origin and history of the HIV-2 epidemic. Proc Natl Acad Sci U S A 2003; 100:6588.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-transmission-natural-history-and-pathogenesis-of-hiv-2-infection/abstract/15\" class=\"nounderline abstract_t\">Wertheim JO, Worobey M. Dating the age of the SIV lineages that gave rise to HIV-1 and HIV-2. PLoS Comput Biol 2009; 5:e1000377.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-transmission-natural-history-and-pathogenesis-of-hiv-2-infection/abstract/16\" class=\"nounderline abstract_t\">van der Loeff MF, Awasana AA, Sarge-Njie R, et al. Sixteen years of HIV surveillance in a West African research clinic reveals divergent epidemic trends of HIV-1 and HIV-2. Int J Epidemiol 2006; 35:1322.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-transmission-natural-history-and-pathogenesis-of-hiv-2-infection/abstract/17\" class=\"nounderline abstract_t\">Eholi&eacute; S, Anglaret X. Commentary: decline of HIV-2 prevalence in West Africa: good news or bad news? Int J Epidemiol 2006; 35:1329.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-transmission-natural-history-and-pathogenesis-of-hiv-2-infection/abstract/18\" class=\"nounderline abstract_t\">da Silva ZJ, Oliveira I, Andersen A, et al. Changes in prevalence and incidence of HIV-1, HIV-2 and dual infections in urban areas of Bissau, Guinea-Bissau: is HIV-2 disappearing? AIDS 2008; 22:1195.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-transmission-natural-history-and-pathogenesis-of-hiv-2-infection/abstract/19\" class=\"nounderline abstract_t\">Hamel DJ, Sankal&eacute; JL, Eisen G, et al. Twenty years of prospective molecular epidemiology in Senegal: changes in HIV diversity. AIDS Res Hum Retroviruses 2007; 23:1189.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-transmission-natural-history-and-pathogenesis-of-hiv-2-infection/abstract/20\" class=\"nounderline abstract_t\">Fryer HR, Van Tienen C, Van Der Loeff MS, et al. Predicting the extinction of HIV-2 in rural Guinea-Bissau. AIDS 2015; 29:2479.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-transmission-natural-history-and-pathogenesis-of-hiv-2-infection/abstract/21\" class=\"nounderline abstract_t\">Larsen O, da Silva Z, Sandstr&ouml;m A, et al. Declining HIV-2 prevalence and incidence among men in a community study from Guinea-Bissau. AIDS 1998; 12:1707.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-transmission-natural-history-and-pathogenesis-of-hiv-2-infection/abstract/22\" class=\"nounderline abstract_t\">Remy G. HIV-2 infection throughout the world. A geographical perspective. Sante 1998; 8:440.</a></li><li class=\"breakAll\">UNAIDS AIDS epidemic update 2006. In: Geneva, Switzerland: Joint United Nations Programme on HIV/AIDS (UNAIDS) and World Health Organization (WHO) 2004; 2006. p.1-94.</li><li><a href=\"https://www.uptodate.com/contents/epidemiology-transmission-natural-history-and-pathogenesis-of-hiv-2-infection/abstract/24\" class=\"nounderline abstract_t\">Centers for Disease Control (CDC). AIDS due to HIV-2 infection--New Jersey. MMWR Morb Mortal Wkly Rep 1988; 37:33.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-transmission-natural-history-and-pathogenesis-of-hiv-2-infection/abstract/25\" class=\"nounderline abstract_t\">Centers for Disease Control and Prevention (CDC). HIV-2 Infection Surveillance--United States, 1987-2009. MMWR Morb Mortal Wkly Rep 2011; 60:985.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-transmission-natural-history-and-pathogenesis-of-hiv-2-infection/abstract/26\" class=\"nounderline abstract_t\">Torian LV, Eavey JJ, Punsalang AP, et al. HIV type 2 in New York City, 2000-2008. Clin Infect Dis 2010; 51:1334.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-transmission-natural-history-and-pathogenesis-of-hiv-2-infection/abstract/27\" class=\"nounderline abstract_t\">L&eacute;onard G, Chaput A, Courgnaud V, et al. Characterization of dual HIV-1 and HIV-2 serological profiles by polymerase chain reaction. AIDS 1993; 7:1185.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-transmission-natural-history-and-pathogenesis-of-hiv-2-infection/abstract/28\" class=\"nounderline abstract_t\">Walther-Jallow L, Andersson S, da Silva Z, Biberfeld G. High concordance between polymerase chain reaction and antibody testing of specimens from individuals dually infected with HIV types 1 and 2 in Guinea-Bissau, West Africa. AIDS Res Hum Retroviruses 1999; 15:957.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-transmission-natural-history-and-pathogenesis-of-hiv-2-infection/abstract/29\" class=\"nounderline abstract_t\">Sarr AD, Hamel DJ, Thior I, et al. HIV-1 and HIV-2 dual infection: lack of HIV-2 provirus correlates with low CD4+ lymphocyte counts. AIDS 1998; 12:131.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-transmission-natural-history-and-pathogenesis-of-hiv-2-infection/abstract/30\" class=\"nounderline abstract_t\">Ishikawa K, Fransen K, Ariyoshi K, et al. Improved detection of HIV-2 proviral DNA in dually seroreactive individuals by PCR. AIDS 1998; 12:1419.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-transmission-natural-history-and-pathogenesis-of-hiv-2-infection/abstract/31\" class=\"nounderline abstract_t\">Travers K, Mboup S, Marlink R, et al. Natural protection against HIV-1 infection provided by HIV-2. Science 1995; 268:1612.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-transmission-natural-history-and-pathogenesis-of-hiv-2-infection/abstract/32\" class=\"nounderline abstract_t\">Sarr AD, Sankal&eacute; JL, Hamel DJ, et al. Interaction with human immunodeficiency virus (HIV) type 2 predicts HIV type 1 genotype. Virology 2000; 268:402.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-transmission-natural-history-and-pathogenesis-of-hiv-2-infection/abstract/33\" class=\"nounderline abstract_t\">Kokkotou EG, Sankale JL, Mani I, et al. In vitro correlates of HIV-2-mediated HIV-1 protection. Proc Natl Acad Sci U S A 2000; 97:6797.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-transmission-natural-history-and-pathogenesis-of-hiv-2-infection/abstract/34\" class=\"nounderline abstract_t\">G&uuml;nthard HF, Huber M, Kuster H, et al. HIV-1 superinfection in an HIV-2-infected woman with subsequent control of HIV-1 plasma viremia. Clin Infect Dis 2009; 48:e117.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-transmission-natural-history-and-pathogenesis-of-hiv-2-infection/abstract/35\" class=\"nounderline abstract_t\">U.S. Public Health Service guidelines for testing and counseling blood and plasma donors for human immunodeficiency virus type 1 antigen. MMWR Recomm Rep 1996; 45:1.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-transmission-natural-history-and-pathogenesis-of-hiv-2-infection/abstract/36\" class=\"nounderline abstract_t\">Meda N, Ndoye I, M'Boup S, et al. Low and stable HIV infection rates in Senegal: natural course of the epidemic or evidence for success of prevention? AIDS 1999; 13:1397.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-transmission-natural-history-and-pathogenesis-of-hiv-2-infection/abstract/37\" class=\"nounderline abstract_t\">Schutz R, Savarit D, Kadjo JC, et al. Excluding blood donors at high risk of HIV infection in a west African city. BMJ 1993; 307:1517.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-transmission-natural-history-and-pathogenesis-of-hiv-2-infection/abstract/38\" class=\"nounderline abstract_t\">Kanki PJ, Travers KU, MBoup S, et al. Slower heterosexual spread of HIV-2 than HIV-1. Lancet 1994; 343:943.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-transmission-natural-history-and-pathogenesis-of-hiv-2-infection/abstract/39\" class=\"nounderline abstract_t\">Comparison of vertical human immunodeficiency virus type 2 and human immunodeficiency virus type 1 transmission in the French prospective cohort. The HIV Infection in Newborns French Collaborative Study Group. Pediatr Infect Dis J 1994; 13:502.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-transmission-natural-history-and-pathogenesis-of-hiv-2-infection/abstract/40\" class=\"nounderline abstract_t\">Adjorlolo-Johnson G, De Cock KM, Ekpini E, et al. Prospective comparison of mother-to-child transmission of HIV-1 and HIV-2 in Abidjan, Ivory Coast. JAMA 1994; 272:462.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-transmission-natural-history-and-pathogenesis-of-hiv-2-infection/abstract/41\" class=\"nounderline abstract_t\">Prazuck T, Yameogo JM, Heylinck B, et al. Mother-to-child transmission of human immunodeficiency virus type 1 and type 2 and dual infection: a cohort study in Banfora, Burkina Faso. Pediatr Infect Dis J 1995; 14:940.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-transmission-natural-history-and-pathogenesis-of-hiv-2-infection/abstract/42\" class=\"nounderline abstract_t\">Gottlieb GS, Hawes SE, Agne HD, et al. Lower levels of HIV RNA in semen in HIV-2 compared with HIV-1 infection: implications for differences in transmission. AIDS 2006; 20:895.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-transmission-natural-history-and-pathogenesis-of-hiv-2-infection/abstract/43\" class=\"nounderline abstract_t\">Burgard M, Jasseron C, Matheron S, et al. Mother-to-child transmission of HIV-2 infection from 1986 to 2007 in the ANRS French Perinatal Cohort EPF-CO1. Clin Infect Dis 2010; 51:833.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-transmission-natural-history-and-pathogenesis-of-hiv-2-infection/abstract/44\" class=\"nounderline abstract_t\">O'Donovan D, Ariyoshi K, Milligan P, et al. Maternal plasma viral RNA levels determine marked differences in mother-to-child transmission rates of HIV-1 and HIV-2 in The Gambia. MRC/Gambia Government/University College London Medical School working group on mother-child transmission of HIV. AIDS 2000; 14:441.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-transmission-natural-history-and-pathogenesis-of-hiv-2-infection/abstract/45\" class=\"nounderline abstract_t\">Hawes SE, Sow PS, Stern JE, et al. Lower levels of HIV-2 than HIV-1 in the female genital tract: correlates and longitudinal assessment of viral shedding. AIDS 2008; 22:2517.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-transmission-natural-history-and-pathogenesis-of-hiv-2-infection/abstract/46\" class=\"nounderline abstract_t\">Simon F, Matheron S, Tamalet C, et al. Cellular and plasma viral load in patients infected with HIV-2. AIDS 1993; 7:1411.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-transmission-natural-history-and-pathogenesis-of-hiv-2-infection/abstract/47\" class=\"nounderline abstract_t\">Marlink R, Kanki P, Thior I, et al. Reduced rate of disease development after HIV-2 infection as compared to HIV-1. Science 1994; 265:1587.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-transmission-natural-history-and-pathogenesis-of-hiv-2-infection/abstract/48\" class=\"nounderline abstract_t\">Gottlieb GS, Sow PS, Hawes SE, et al. Equal plasma viral loads predict a similar rate of CD4+ T cell decline in human immunodeficiency virus (HIV) type 1- and HIV-2-infected individuals from Senegal, West Africa. J Infect Dis 2002; 185:905.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-transmission-natural-history-and-pathogenesis-of-hiv-2-infection/abstract/49\" class=\"nounderline abstract_t\">Gilbert PB, McKeague IW, Eisen G, et al. Comparison of HIV-1 and HIV-2 infectivity from a prospective cohort study in Senegal. Stat Med 2003; 22:573.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-transmission-natural-history-and-pathogenesis-of-hiv-2-infection/abstract/50\" class=\"nounderline abstract_t\">MacNeil A, Sarr AD, Sankal&eacute; JL, et al. Direct evidence of lower viral replication rates in vivo in human immunodeficiency virus type 2 (HIV-2) infection than in HIV-1 infection. J Virol 2007; 81:5325.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-transmission-natural-history-and-pathogenesis-of-hiv-2-infection/abstract/51\" class=\"nounderline abstract_t\">Popper SJ, Sarr AD, Travers KU, et al. Lower human immunodeficiency virus (HIV) type 2 viral load reflects the difference in pathogenicity of HIV-1 and HIV-2. J Infect Dis 1999; 180:1116.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-transmission-natural-history-and-pathogenesis-of-hiv-2-infection/abstract/52\" class=\"nounderline abstract_t\">Poulsen AG, Aaby P, Larsen O, et al. 9-year HIV-2-associated mortality in an urban community in Bissau, west Africa. Lancet 1997; 349:911.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-transmission-natural-history-and-pathogenesis-of-hiv-2-infection/abstract/53\" class=\"nounderline abstract_t\">Martinez-Steele E, Awasana AA, Corrah T, et al. Is HIV-2- induced AIDS different from HIV-1-associated AIDS? Data from a West African clinic. AIDS 2007; 21:317.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-transmission-natural-history-and-pathogenesis-of-hiv-2-infection/abstract/54\" class=\"nounderline abstract_t\">Schim van der Loeff MF, Jaffar S, Aveika AA, et al. Mortality of HIV-1, HIV-2 and HIV-1/HIV-2 dually infected patients in a clinic-based cohort in The Gambia. AIDS 2002; 16:1775.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-transmission-natural-history-and-pathogenesis-of-hiv-2-infection/abstract/55\" class=\"nounderline abstract_t\">Sousa AE, Carneiro J, Meier-Schellersheim M, et al. CD4 T cell depletion is linked directly to immune activation in the pathogenesis of HIV-1 and HIV-2 but only indirectly to the viral load. J Immunol 2002; 169:3400.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-transmission-natural-history-and-pathogenesis-of-hiv-2-infection/abstract/56\" class=\"nounderline abstract_t\">MacNeil A, Sankale JL, Meloni ST, et al. Long-term intrapatient viral evolution during HIV-2 infection. J Infect Dis 2007; 195:726.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-transmission-natural-history-and-pathogenesis-of-hiv-2-infection/abstract/57\" class=\"nounderline abstract_t\">Andersson S, Norrgren H, da Silva Z, et al. Plasma viral load in HIV-1 and HIV-2 singly and dually infected individuals in Guinea-Bissau, West Africa: significantly lower plasma virus set point in HIV-2 infection than in HIV-1 infection. Arch Intern Med 2000; 160:3286.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-transmission-natural-history-and-pathogenesis-of-hiv-2-infection/abstract/58\" class=\"nounderline abstract_t\">Leligdowicz A, Yindom LM, Onyango C, et al. Robust Gag-specific T cell responses characterize viremia control in HIV-2 infection. J Clin Invest 2007; 117:3067.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-transmission-natural-history-and-pathogenesis-of-hiv-2-infection/abstract/59\" class=\"nounderline abstract_t\">Duvall MG, Jaye A, Dong T, et al. Maintenance of HIV-specific CD4+ T cell help distinguishes HIV-2 from HIV-1 infection. J Immunol 2006; 176:6973.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-transmission-natural-history-and-pathogenesis-of-hiv-2-infection/abstract/60\" class=\"nounderline abstract_t\">Angin M, Wong G, Papagno L, et al. Preservation of Lymphopoietic Potential and Virus Suppressive Capacity by CD8+ T Cells in HIV-2-Infected Controllers. J Immunol 2016; 197:2787.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-transmission-natural-history-and-pathogenesis-of-hiv-2-infection/abstract/61\" class=\"nounderline abstract_t\">Matheron S, Pueyo S, Damond F, et al. Factors associated with clinical progression in HIV-2 infected-patients: the French ANRS cohort. AIDS 2003; 17:2593.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-transmission-natural-history-and-pathogenesis-of-hiv-2-infection/abstract/62\" class=\"nounderline abstract_t\">Nkengasong JN, Kestens L, Ghys PD, et al. Dual infection with human immunodeficiency virus type 1 and type 2: impact on HIV type 1 viral load and immune activation markers in HIV-seropositive female sex workers in Abidjan, Ivory Coast. AIDS Res Hum Retroviruses 2000; 16:1371.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-transmission-natural-history-and-pathogenesis-of-hiv-2-infection/abstract/63\" class=\"nounderline abstract_t\">Greenberg AE. Possible protective effect of HIV-2 against incident HIV-1 infection: review of available epidemiological and in vitro data. AIDS 2001; 15:2319.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-transmission-natural-history-and-pathogenesis-of-hiv-2-infection/abstract/64\" class=\"nounderline abstract_t\">Alabi AS, Jaffar S, Ariyoshi K, et al. Plasma viral load, CD4 cell percentage, HLA and survival of HIV-1, HIV-2, and dually infected Gambian patients. AIDS 2003; 17:1513.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-transmission-natural-history-and-pathogenesis-of-hiv-2-infection/abstract/65\" class=\"nounderline abstract_t\">Koblavi-D&egrave;me S, Kestens L, Hanson D, et al. Differences in HIV-2 plasma viral load and immune activation in HIV-1 and HIV-2 dually infected persons and those infected with HIV-2 only in Abidjan, C&ocirc;te D'Ivoire. AIDS 2004; 18:413.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-transmission-natural-history-and-pathogenesis-of-hiv-2-infection/abstract/66\" class=\"nounderline abstract_t\">Borget MY, Diallo K, Adje-Toure C, et al. Virologic and immunologic responses to antiretroviral therapy among HIV-1 and HIV-2 dually infected patients: case reports from Abidjan, C&ocirc;te d'Ivoire. J Clin Virol 2009; 45:72.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-transmission-natural-history-and-pathogenesis-of-hiv-2-infection/abstract/67\" class=\"nounderline abstract_t\">Landman R, Damond F, Gerbe J, et al. Immunovirological and therapeutic follow-up of HIV-1/HIV-2-dually seropositive patients. AIDS 2009; 23:426.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-transmission-natural-history-and-pathogenesis-of-hiv-2-infection/abstract/68\" class=\"nounderline abstract_t\">Esbj&ouml;rnsson J, M&aring;nsson F, Kvist A, et al. Inhibition of HIV-1 disease progression by contemporaneous HIV-2 infection. N Engl J Med 2012; 367:224.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-transmission-natural-history-and-pathogenesis-of-hiv-2-infection/abstract/69\" class=\"nounderline abstract_t\">van Tienen C, Schim van der Loeff M, Peterson I, et al. HTLV-1 and HIV-2 infection are associated with increased mortality in a rural West African community. PLoS One 2011; 6:e29026.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-transmission-natural-history-and-pathogenesis-of-hiv-2-infection/abstract/70\" class=\"nounderline abstract_t\">Prince PD, Matser A, van Tienen C, et al. Mortality rates in people dually infected with HIV-1/2 and those infected with either HIV-1 or HIV-2: a systematic review and meta-analysis. AIDS 2014; 28:549.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-transmission-natural-history-and-pathogenesis-of-hiv-2-infection/abstract/71\" class=\"nounderline abstract_t\">Esbj&ouml;rnsson J, M&aring;nsson F, Kvist A, et al. Increased survival among HIV-1 and HIV-2 dual-infected individuals compared to HIV-1 single-infected individuals. AIDS 2014; 28:949.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-transmission-natural-history-and-pathogenesis-of-hiv-2-infection/abstract/72\" class=\"nounderline abstract_t\">Brenchley JM, Price DA, Schacker TW, et al. Microbial translocation is a cause of systemic immune activation in chronic HIV infection. Nat Med 2006; 12:1365.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-transmission-natural-history-and-pathogenesis-of-hiv-2-infection/abstract/73\" class=\"nounderline abstract_t\">Leligdowicz A, Feldmann J, Jaye A, et al. Direct relationship between virus load and systemic immune activation in HIV-2 infection. J Infect Dis 2010; 201:114.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-transmission-natural-history-and-pathogenesis-of-hiv-2-infection/abstract/74\" class=\"nounderline abstract_t\">Levy JA. HIV pathogenesis: 25 years of progress and persistent challenges. AIDS 2009; 23:147.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-transmission-natural-history-and-pathogenesis-of-hiv-2-infection/abstract/75\" class=\"nounderline abstract_t\">Ancuta P, Kamat A, Kunstman KJ, et al. Microbial translocation is associated with increased monocyte activation and dementia in AIDS patients. PLoS One 2008; 3:e2516.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-transmission-natural-history-and-pathogenesis-of-hiv-2-infection/abstract/76\" class=\"nounderline abstract_t\">Redd AD, Dabitao D, Bream JH, et al. Microbial translocation, the innate cytokine response, and HIV-1 disease progression in Africa. Proc Natl Acad Sci U S A 2009; 106:6718.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-transmission-natural-history-and-pathogenesis-of-hiv-2-infection/abstract/77\" class=\"nounderline abstract_t\">Michel P, Balde AT, Roussilhon C, et al. Reduced immune activation and T cell apoptosis in human immunodeficiency virus type 2 compared with type 1: correlation of T cell apoptosis with beta2 microglobulin concentration and disease evolution. J Infect Dis 2000; 181:64.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-transmission-natural-history-and-pathogenesis-of-hiv-2-infection/abstract/78\" class=\"nounderline abstract_t\">Nowroozalizadeh S, M&aring;nsson F, da Silva Z, et al. Microbial translocation correlates with the severity of both HIV-1 and HIV-2 infections. J Infect Dis 2010; 201:1150.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-transmission-natural-history-and-pathogenesis-of-hiv-2-infection/abstract/79\" class=\"nounderline abstract_t\">Hegedus A, Nyamweya S, Zhang Y, et al. Protection versus pathology in aviremic and high viral load HIV-2 infection-the pivotal role of immune activation and T-cell kinetics. J Infect Dis 2014; 210:752.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-transmission-natural-history-and-pathogenesis-of-hiv-2-infection/abstract/80\" class=\"nounderline abstract_t\">Buggert M, Frederiksen J, Lund O, et al. CD4+ T cells with an activated and exhausted phenotype distinguish immunodeficiency during aviremic HIV-2 infection. AIDS 2016; 30:2415.</a></li></ol></div><div id=\"topicVersionRevision\">Topic 13966 Version 9.0</div></div>","outline":"<div id=\"outlineSections\"><h2>Topic Outline</h2><ul id=\"innerOutline\"><li class=\"sr-button\"><a href=\"#H603396\"><span>SUMMARY &amp; RECOMMENDATIONS</span></a></li><li><a href=\"#H13491378\" id=\"outline-link-H13491378\">INTRODUCTION</a></li><li><a href=\"#H1426447\" id=\"outline-link-H1426447\">EPIDEMIOLOGY</a><ul><li><a href=\"#H1427234\" id=\"outline-link-H1427234\">Origin of the epidemic</a></li><li><a href=\"#H1427152\" id=\"outline-link-H1427152\">HIV-2 in West Africa</a></li><li><a href=\"#H1427159\" id=\"outline-link-H1427159\">HIV-2 outside West Africa</a></li><li><a href=\"#H1426891\" id=\"outline-link-H1426891\">Dual infection with HIV-1 and HIV-2</a></li></ul></li><li><a href=\"#H1427133\" id=\"outline-link-H1427133\">TRANSMISSION</a><ul><li><a href=\"#H60762404\" id=\"outline-link-H60762404\">Routes of transmission</a></li><li><a href=\"#H60762411\" id=\"outline-link-H60762411\">Risk of transmission</a></li></ul></li><li><a href=\"#H13491385\" id=\"outline-link-H13491385\">NATURAL HISTORY</a><ul><li><a href=\"#H151845\" id=\"outline-link-H151845\">HIV-2 is less pathogenic than HIV-1</a><ul><li><a href=\"#H60761993\" id=\"outline-link-H60761993\">- Risk of AIDS</a></li><li><a href=\"#H2601006\" id=\"outline-link-H2601006\">- Risk of death</a></li><li><a href=\"#H60762000\" id=\"outline-link-H60762000\">- Lower levels of viremia</a></li></ul></li><li><a href=\"#H2600297\" id=\"outline-link-H2600297\">Natural history among dually infected patients</a></li></ul></li><li><a href=\"#H60762064\" id=\"outline-link-H60762064\">PATHOGENESIS</a></li><li><a href=\"#H603396\" id=\"outline-link-H603396\">SUMMARY AND RECOMMENDATIONS</a></li><li><a href=\"#references\">REFERENCES</a></li></ul></div><div><h2>RELATED TOPICS</h2><div id=\"outlineTopics\"><ul><li class=\"plainItem\"><a href=\"topic.htm?path=clinical-manifestations-and-diagnosis-of-hiv-2-infection\" class=\"medical medical_review\">Clinical manifestations and diagnosis of HIV-2 infection</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=global-epidemiology-of-hiv-infection\" class=\"medical medical_review\">Global epidemiology of HIV infection</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=treatment-of-hiv-2-infection\" class=\"medical medical_review\">Treatment of HIV-2 infection</a></li></ul></div></div>","javascript":null}